Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II double-blind multicenter active-controlled study of Zifa01 for acute symptomatic deep vein thrombosis
CTR20211142Phase 2Active
- Sponsor
- Tianjin Institute of Pharmaceutical Research
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zifaxaban in deep vein thrombosis (DVT), sponsored by Tianjin Institute of Pharmaceutical Research. Started Aug 2021; status: active.
02
Drugs
zifaxaban
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on CTR20211142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211142.